• TEXT SIZE

ENBREL Support™ Card

Join more than 200,000 people who have used our card.

The ENBREL Support™ card provides financial support to eligible* commercially insured patients when presented to the pharmacy.

ENBREL is an injectable prescription medication that treats moderately to severely active rheumatoid arthritis, adult chronic moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy, psoriatic arthritis, ankylosing spondylitis, and moderately to severely active polyarticular juvenile idiopathic arthritis. ENBREL is not for everyone. Serious side effects are possible. Make sure you read and understand the Important Safety Information and Indications for ENBREL.

For all eligible patients*, the ENBREL Support™ card program may offer:

  • First 6 months at no out-of-pocket cost to you
  • After 6 months, $10 or less out-of-pocket per month
  • Support for your ENBREL co-pay or co-insurance and prescription deductible

*Read eligibility criteria & limits‡§


Sign up for support

Misplaced your card?

Replace your card now

Need to renew for another year?

Get Started HERE


Please see Prescribing Information, Important Safety Information, and Medication Guide for complete details about ENBREL.


busy

Prescription ENBREL is taken by injection.

IMPORTANT SAFETY INFORMATION
Indications

Moderate to Severe Rheumatoid Arthritis (RA)
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderate to severe rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.

Moderately to Severely Active Polyarticular Juvenile Idiopathic Arthritis (JIA)
ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older.

Psoriatic Arthritis
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with psoriatic arthritis. ENBREL can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone.

Ankylosing Spondylitis (AS)
ENBREL is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis.

Moderate to Severe Plaque Psoriasis
ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Has your insurance changed?

ENBREL Support™ can help you understand if there are any changes in coverage for ENBREL. Call us at 1-888-4ENBREL (1-888-436-2735) and we can check your coverage, including your co-pay and deductible costs.

Verify Coverage Now